FedEx to invest $1.5 billion in France to double capacity at Roissy airpor…
PARIS Package delivery company FedEx Corp (FDX.N) said on Tuesday it would invest 1.4 billion euros (£1.5 billion) to double the capacity of its logistics activities at Charles de Gaulle International Airport in the Paris suburb of Roissy.
The initial investment by the U.S-listed firm will amount to 200 million euros (£220 million) for the extension of its facility in Roissy, the remaining 1.2 billion euros representing the guaranteed total amount of rent over 30 years.
Under the plan, the U.S. group plans to open a new package sorting facility in 2019, creating between 200 and 400 jobs, according to a document handed out during a visit by President Francois Hollande.
“The opening of this facility is an additional sign of France’s attractiveness,” Hollande said.
“With the decision by Britons to leave the European Union, it should lead us to attract even more investments,” he added.
The extra 25,000 square meters of space will make FedEx’s Roissy center its second biggest in the world after the one in Memphis in the United States.
Delivery service company TNT Express, which was bought in May by FedEx, also plans to open a new facility in the Parisian region, according to the same document.
(Reporting by Jean-Baptiste Vey; Writing by Mathieu Rosemain; Editing by Andrew Callus and Mark Potter)
Next In Business News
Wall St. set to open higher on Goldman, Netflix results
Wall Street was set for a higher open on Tuesday, buoyed by a slew of better-than-expected quarterly reports, including from Netflix and Goldman Sachs.
Once jobless and uncounted, eager workers could slow Fed rate hike
WELLSTON, Missouri The crammed-to-capacity parking lot at a job training center in this St.
Louis suburb is exhibit A for why the U.S.
Federal Reserve remains at odds over the health of the U.S. labor market and how quickly interest rates should rise.
J&J revenue, profit edge past estimates on robust drug sales
Johnson & Johnson , the world’s largest maker of healthcare products, reported third-quarter revenue and profit just ahead of Wall Street estimates, fueled by strong sales in its prescription drugs business.